Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings
- Resource Type
- Article
- Source
- In
Journal of Microbiology, Immunology and Infection August 2019 52(4):556-562 - Subject
- Language
- ISSN
- 1684-1182